Angiology: Open Access

Angiology: Open Access
Open Access

ISSN: 2329-9495

+44 1478 350008

Harsh Golwala

Harsh Golwala

Harsh Golwala
Advanced Interventional Cardiology Fellow, Brigham and Women's Hospital
Boston, MA, USA

Biography

Dr. Harsh Golwala, MD, is an advanced interventional cardiology fellow at the Brigham and Women’s Hospital Heart & Vascular Center at Harvard Medical School, Boston, MA. He is currently training in complex coronary, peripheral and structural heart interventions. After receiving his medical doctorate with top honors from the Government Medical College, Surat, India, he moved to the United States. His internship and residency training were performed at the University of Oklahoma Health Sciences Center, Oklahoma City, OK. During his training, Dr. Golwala was awarded with the prestigious American Heart Association Young Investigator Database Seed Research grant under the mentorships of Dr. Deepak Bhatt (Brigham and Women’s Hospital, Boston, MA) and Dr. Gregg Fonarow (University of California, Los Angeles, CA). His cardiovascular training was completed at the University of Louisville, Louisville, KY where he was awarded with the American College of Cardiology (ACC) Legislative and Leadership Awards. He also served as the ACC FIT Liaison (2013- 2016) and played a major role as a part of planning committee for ACC KY Chapter Annual Scientific meetings. Dr. Golwala has presented more than 30 abstracts at national and international meetings, and published more than 40 manuscripts in various peer reviewed journals. His current area of investigation focuses on antiplatelet and anticoagulation therapies for various cardiovascular conditions viz. coronary, peripheral and valvular heart diseases. He also has a specific interest in outcomes research and has demonstrated his commitment to the field by publishing first author publications in top cardiovascular journals viz. Journal of American College of Cardiology, Circulation and European Heart Journal. He currently also serves as a sub- investigator for the EVOLVE II and RADIANCE HTN randomized controlled trials under the leadership of Dr. Laura Mauri (Brigham and Women’s Hospital, Boston, MA). His future areas of research focus on evaluating cardiovascular devices and therapies in both clinical trials and observational studies, with an emphasis on understanding methods to improve the value of new technologies as they are implemented in clinical practice.

Research Interest

Complex coronary, peripheral and structural heart interventions

Top